IO BIOTECH INC. - COM
1,0600
07-октября-24 15:59:55
15 мин. задержка
Акции
-0,0900
-7,83%
Сегодняшний диапазон
1,0600 - 1,1700
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
04 окт 2024 09:00:00 Источник Nasdaq GlobeNewswire
-
14 сен 2024 02:30:00 Источник Nasdaq GlobeNewswire
-
30 авг 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
IO Biotech Announces Participation in Upcoming Investor Conferences
26 авг 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
IO Biotech Reports Second Quarter 2024 Financial Results and Provides Business Highlights
13 авг 2024 07:05:00 Источник Nasdaq GlobeNewswire
-
IO Biotech Announces New Head and Neck Cohort Data Accepted for Presentation at ESMO Congress 2024
25 июл 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
IO Biotech to Present at Jefferies Global Healthcare Conference
23 май 2024 08:30:00 Источник Nasdaq GlobeNewswire
-
IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
14 май 2024 07:55:00 Источник Nasdaq GlobeNewswire
-
24 апр 2024 16:30:00 Источник Nasdaq GlobeNewswire
-
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
15 апр 2024 08:30:00 Источник Nasdaq GlobeNewswire
-
09 апр 2024 12:00:00 Источник Nasdaq GlobeNewswire
-
IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer
05 апр 2024 08:30:00 Источник Nasdaq GlobeNewswire
-
06 мар 2024 16:11:01 Источник Nasdaq GlobeNewswire
-
IO Biotech Announces 2023 Fourth-Quarter and Year-End Results
05 мар 2024 16:40:01 Источник Nasdaq GlobeNewswire
-
IO Biotech to Present at 44th Annual Cowen Health Care Conference
26 фев 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
IO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial
21 дек 2023 08:30:00 Источник Nasdaq GlobeNewswire
-
IO Biotech Announces 2023 Third Quarter Results
13 ноя 2023 08:12:16 Источник Nasdaq GlobeNewswire
-
IO Biotech Appoints Helen Collins, MD, to its Board of Directors
13 ноя 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
IO Biotech Completes Enrollment of 380 Patients in Pivotal Phase 3 Trial in Advanced Melanoma
10 ноя 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
IO Biotech Announces Participation in Upcoming Investor Conferences
08 ноя 2023 16:30:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >